Company / Free Cash Flow
ORAGENICS INC Free Cash Flow History
FY2013-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$15.4M
FY2023
5-year range
-$15.4M / -$9.2M
FY2019-FY2023
Trend
-13.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$14M to -$15M over the past 2 years.
Based on SEC 10-K filings.
-$15M in FY2023.
Declined from -$14M to -$15M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, free cash flow decreased 13.6% year-over-year.
- Peak free cash flow was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -147.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -$15.4M | -13.6% |
| FY2022 | -$13.5M | +0.0% |
| FY2021 | -$13.5M | -46.8% |
| FY2018 | -$9.2M | -29.6% |
| FY2017 | -$7.1M | -34.2% |
| FY2016 | -$5.3M | +6.7% |
| FY2015 | -$5.7M | +0.0% |
| FY2014 | -$5.7M | -8.6% |
| FY2013 | -$5.2M | +0.0% |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026